• OPEN AN ACCOUNT
Indian Indices
Sensex
77,966.35 -187.90
( -0.24%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,825.49 -18.70
(-0.17%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
31.71
60.92
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Urja Global consolidated net profit rises 66.67% in the March 2026 quarter
May 22,2026
Net profit of Urja Global rose 66.67% to Rs 0.20 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales rose 2.33% to Rs 17.58 crore in the quarter ended March 2026 as against Rs 17.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.51% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.27 crore during the previous year ended March 2025. Sales declined 0.82% to Rs 66.70 crore in the year ended March 2026 as against Rs 67.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.5817.18 2 66.7067.25 -1
OPM %2.674.13 -3.192.66 -
PBDT0.470.92 -49 2.482.41 3
PBT0.360.81 -56 1.992.03 -2
NP0.200.12 67 1.341.27 6